Practices of patient engagement in drug development: a systematic scoping review.

ABSTRACT:

Background

During the past decade, patient engagement (PE) has attracted significant attention in the field of drug development. Readiness to accept the central importance of patients' knowledge and contributions has become evident. This study aimed to synthesize evidence on the current state of PE in drug development: what is actually being done and how.

Methods

A systematic scoping review was conducted based on a PRISMA-informed protocol. Search was performed in PubMed, EMBASE and Web of Science, covering the period between 2011 and 2021. For analysis of extracted data, we developed a framework for analyzing PE in Drug Development. The Framework distinguishes a number of different PE types that take place at different stages of drug development and are characterized by the

SUBMITTER: Zvonareva O 

PROVIDER: S-EPMC9243835 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature